Feb 19, 2019
Autolus Therapeutics Announces Updated Results from Ongoing CARPALL Trial of Pediatric Acute Lymphoblastic Leukemia Presented at the EHA 1st European CAR T Cell Meeting in Paris
Jan 22, 2019
European Commission Approves BLINCYTO® (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia
Jan 07, 2019
In Promise of True Liquid Biopsy for Cancer, Chip Company BioFluidica® Awarded $1.7 Million by National Cancer Institute/National Institutes of Health for Clinical Trial in Children with Acute Lymphoblastic Leukemia
Sep 04, 2018
Medicine X Launches Story To Educate Cancer Patients
Aug 29, 2018
European Commission Approves BLINCYTO® (blinatumomab) For Use In Pediatric Patients With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Jun 16, 2018
European Hematology Association: A New Anti-CD22 CAR-T Immunotherapy Saved Life of Children With Leukemia
May 16, 2018
In Promise of True Liquid Biopsy for Cancer, BioFluidica® Launches Human Trial for Rapid Detection of Minimal Residual Disease in Acute Myeloid Leukemia from Peripheral Blood Using high through-put automation and programmable Microfluidic Chips
Apr 18, 2018
For Young Adults with Blood Cancer, Pediatric Centers May Improve Survival
Apr 06, 2018
BESPONSA(TM) Approved by Health Canada for the Treatment of Adults with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
Apr 03, 2018
Curewize Successfully Completed Clinical Trial on Lab Test Revealing Acute Lymphoblastic Leukemia Patients' Optimal Treatment Regimen
Mar 29, 2018
FDA Approves BLINCYTO® (blinatumomab) To Treat Minimal Residual Disease-Positive B-Cell Precursor Acute Lymphoblastic Leukemia In Adults And Children
Mar 29, 2018
FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse
Mar 12, 2018
Publication in Blood Advances® Reports that the Combination of Cantex Pharmaceuticals' CX-01 with Chemotherapy for the Treatment of Acute Myeloid Leukemia Showed Encouraging Complete Remission Rates and Rapid Platelet Count Recovery
Jan 31, 2018
T Cell Therapy Shows Persistent Benefits in Young Leukemia Patients
Dec 07, 2017
John Quinones, Host of ABC's What Would You Do? Appears with Children and Adult Blood Cancer Survivors In PSA for The Leukemia & Lymphoma Society
Dec 07, 2017
John Quinones, Host of ABC's What Would You Do? Appears with Children and Adult Blood Cancer Survivors In PSA for The Leukemia & Lymphoma Society
Dec 04, 2017
Final Results of the Phase I/II Clinical Study of BST-236 in Acute Leukemia Patients will be Presented at the 2017 Annual ASH Meeting
Nov 28, 2017
The Global Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market Is Expected To Reach Usd 3.4 Billion By 2025
Oct 18, 2017
Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Worth $3.4 Billion By 2025: Grand View Research, Inc.
Aug 31, 2017
FDA Approves Groundbreaking CAR T Cell Therapy for Kids With Leukemia